Marketing-authorisation holder · United States
Springworks
3 medicines in 1 country, as authorisation holder.
Group structure
Other companies in the group
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| GOMEKLI1mg | 2mg · Capsule | Mirdametinib | United States | Marketed | 2025 |
| GOMEKLI1MG · Tablet, for suspension | Mirdametinib | United States | Marketed | 2025 |
| OGSIVEO100mg base | 150mg base | 50mg base · Tablet | Nirogacestat | United States | Marketed | 2023 |